Cargando…
Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
Ovarian cancer is one of the leading causes of cancer-related death among women. Resistance to the disease occurs in more than 70% of the cases even after treated with chemotherapy agents such as paclitaxel- and platinum-based agents. The immune system is increasingly becoming a target for intense r...
Autores principales: | Gavalas, Nikos G., Karadimou, Alexandra, Dimopoulos, Meletios A., Bamias, Aristotelis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034919/ https://www.ncbi.nlm.nih.gov/pubmed/21318181 http://dx.doi.org/10.1155/2010/791603 |
Ejemplares similares
-
The role of high-dose chemotherapy in the treatment of testicular cancer
por: Karadimou, Alexandra, et al.
Publicado: (2010) -
Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
por: Gavalas, Nikos G., et al.
Publicado: (2013) -
Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis
por: Karadimou, Alexandra, et al.
Publicado: (2010) -
Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2015) -
Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2021)